Chesnara plc (LON:CSN - Get Free Report) insider Steve Murray bought 11,012 shares of the firm's stock in a transaction dated Friday, March 28th. The stock was purchased at an average price of GBX 272 ($3.51) per share, with a total value of £29,952.64 ($38,698.50).
Chesnara Stock Up 0.2 %
Shares of LON CSN traded up GBX 0.50 ($0.01) during midday trading on Tuesday, reaching GBX 276 ($3.57). 594,853 shares of the company's stock were exchanged, compared to its average volume of 207,867. The company has a debt-to-equity ratio of 62.42, a quick ratio of 38.06 and a current ratio of 2.55. Chesnara plc has a 52-week low of GBX 240 ($3.10) and a 52-week high of GBX 289.50 ($3.74). The business's fifty day moving average price is GBX 265.37 and its two-hundred day moving average price is GBX 259.93. The stock has a market capitalization of £419.95 million, a PE ratio of 100.66 and a beta of 0.44.
Chesnara (LON:CSN - Get Free Report) last announced its earnings results on Friday, March 28th. The company reported GBX 2.56 ($0.03) earnings per share (EPS) for the quarter. Chesnara had a return on equity of 1.21% and a net margin of 1.02%. Analysts forecast that Chesnara plc will post 25.3183154 EPS for the current year.
Chesnara Increases Dividend
The company also recently disclosed a dividend, which will be paid on Monday, April 14th. Investors of record on Thursday, April 10th will be issued a GBX 23.95 ($0.31) dividend. This is a positive change from Chesnara's previous dividend of $8.61. This represents a yield of 4.24%. The ex-dividend date of this dividend is Thursday, April 10th. Chesnara's payout ratio is currently 875.33%.
Chesnara Company Profile
(
Get Free Report)
Chesnara (CSN.L) is a European life and pensions consolidator listed on the London Stock Exchange. It administers approximately one million policies and operates as Countrywide Assured in the UK, as The Waard Group and Scildon in the Netherlands, and as Movestic in Sweden.
Following a three-pillar strategy, Chesnara's primary responsibility is the efficient administration of its customers' life and savings policies, ensuring good customer outcomes and providing a secure and compliant environment to protect policyholder interests.
Featured Articles
Before you consider Chesnara, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chesnara wasn't on the list.
While Chesnara currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.